A prospective, multicenter case-control study published in PLoS Medicine in 2025 described the frequency and clinical characteristics of patients with a protracted post-Covid course and searched for risk factors for persistence vs. improvement of symptoms. The analyses showed that in two thirds of the patients who had a post-Covid syndrome 6-12 months after acute SARS-CoV-2 infection, symptoms persisted in the following months.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Obesity as a chronic disease: an interdisciplinary perspective
Neurobiological mechanisms of obesity
- Oncolytic virus in stage II melanoma
Innovative method for predicting therapy response
- Phimosis and penile cancer under SGLT2i
Increased risk for men with T2D
- Diabetic ketoacidosis
Recommendations for action in practice
- Migraine: better quality of life thanks to multimodal care
Broader selection of innovative migraine prophylactics and acute therapies
- Therapy of non-tumor-related pain
Do not prescribe opioids lightly for musculoskeletal pain
- "Forgotten axis" between plant substances, gut and systemic health
Microbiome and phytotherapy
- Migraine